Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on the minutes of the Board of Directors meeting held on March 28, 2025. The filing covers corporate governance actions, including the proposal for net profit allocation for the fiscal year ended December 31, 2024, the approval of management compensation limits for 2025, and a capital increase resulting from stock option exercises. The filing also announces the removal of the previous Chief Financial Officer and the election of a successor effective April 1, 2025.
Key Financial Metrics
- Net Profits (FY 2024): R$14,437,237,749.00
- Interest on Own Capital (JCP): R$10,505,388,233.75 (declared based on FY 2023 net profit)
- Tax Incentives Reserve Allocation: R$108,125,431.35
- Investments Reserve Allocation: R$10,339,054,767.31 (includes R$6.48 billion related to IAS 29/CPC 42 hyperinflation effects)
- Capital Increase (March 28, 2025): R$49,051,094.40 from the issuance of 3,981,420 new common shares.
- Total Capital Stock (Post-Increase): R$58,275,086,270.41
- Proposed Management Compensation Cap (FY 2025): R$249,548,559.00
- Proposed Fiscal Council Compensation Cap (FY 2025): R$2,455,546.00
Note: The filing does not provide specific revenue, operating cash flow, or debt figures for the current period.
Material Changes
- Capital Structure: The company executed a capital increase of approximately R$49 million, raising the total number of registered common shares to 15,761,638,756.
- Executive Leadership: Mr. Lucas Machado Lira was removed from the position of Chief Financial, Investor Relations, and Shared Services Officer. Mr. Guilherme Fleury de Figueiredo Ferraz Parolari was elected to the same position effective April 1, 2025, with a term ending December 31, 2027.
- Profit Allocation: The Board approved a proposal to allocate the majority of FY 2024 net profits to the Investments Reserve, driven significantly by accounting adjustments for hyperinflation (IAS 29/CPC 42).
Guidance, Outlook, and Corporate Actions
- Shareholder Meetings: Ordinary and Extraordinary General Meetings are scheduled for April 29, 2025, to be held exclusively in a digital format. Agenda items include approving FY 2024 financial statements, voting on profit allocation, electing the Fiscal Council, and ratifying management compensation for 2025.
- Bylaws Amendment: The Board approved a proposal to amend and consolidate the Company's Bylaws to reflect recent capital increases.
- Stock Option Plan: The capital increase was executed pursuant to the Company's Stock Option Plan 1, with new shares participating equally in all benefits declared as of the issuance date.
Investor Verification Checklist
- Verify the final approval of the FY 2024 net profit allocation and the specific breakdown of the Investments Reserve at the April 29, 2025, Shareholders' Meeting.
- Confirm the transition of duties for the Chief Financial Officer role and review the new officer's background and compensation structure.
- Review the full FY 2024 financial statements (published February 26, 2025) to understand the context of the R$6.48 billion hyperinflation adjustment included in the Investments Reserve.
- Monitor the implementation of the proposed 2025 management compensation limits once ratified by shareholders.